Drug Database
Back to search

Japan· JP-4291410A1070

オキサリプラチン

A oxaliplatin product containing オキサリプラチン, registered in Japan by 第一三共エスファ, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

On Japan’s NHI price listATC L01XA03

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedオキサリプラチンATCL01XA03REGISTER NO.JP-4291410A1070PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about オキサリプラチンAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Oxaliplatin is registered in 17 of 19 countries.

Countries holding a registration under ATC L01XA03 (oxaliplatin), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 9 of them publish a price we can compare per daily dose
Search oxaliplatin products by name

Oxaliplatin · ATC L01XA03

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxaliplatin costs, country by country.

Normalised to the WHO defined daily dose (11 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Oxaliplatin · price per daily dose (11 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$24.21
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
オキサリプラチン
Manufacturer
第一三共エスファ
Country
Japan (JP)
ATC code
L01XA03
ATC class
Oxaliplatin
Defined daily dose
11 mg, P
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

740 interactions on record for oxaliplatin.

Graded by severity as the source publishes them — 101 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check oxaliplatin against other medicinesHow interaction checks work

Oxaliplatin · interactions on record

740 records

  • 101 severe
  • 453 moderate
  • 1 minor
  • 185 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under L01XA03

Oxaliplatin, as other registers publish it.

All oxaliplatin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ea970f9b-fd93-4618-9646-c1b98f6bc1bb
GET /v1/drugs/ea970f9b-fd93-4618-9646-c1b98f6bc1bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "５０ｍｇ１０ｍＬ１瓶",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "4291410A1070",
  "category": "注射薬",
  "price_yen": 4821,
  "generic_name": "オキサリプラチン",
  "product_name_jp": null,
  "therapeutic_class": "4291",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about oxaliplatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console